Investigation of medication in secondary prevention in patents with ischemic stroke in Tangshan

MENG Linghai,LI Jiong,ZHANG Heqi,SHANG Shuling,and YU Xinyang.

Medical Journal of the Chinese People Armed Police Forces ›› 2012, Vol. 23 ›› Issue (9) : 761-762.

PDF(413 KB)
PDF(413 KB)
Medical Journal of the Chinese People Armed Police Forces ›› 2012, Vol. 23 ›› Issue (9) : 761-762.

Investigation of medication in secondary prevention in patents with ischemic stroke in Tangshan

  • MENG Linghai,LI Jiong,ZHANG Heqi,SHANG Shuling,and YU Xinyang.
Author information +
History +

Abstract

Objective To investigate the knowledge and use of antithrombotic and lipid-regulating medicines in Tangshan. Methods Using a self-designed questionnaire, a survey was conducted in a total of 635 patients with ischemic stroke by random sampling method in eight communities in Lunan and Lubei Districts. Unified analysis of the questionnaires was carried out. Results A total of 635 valid questionnaires were returned. The proportion of people who had some knowledge of and used antithrombotic agents was 89.3% and 61.4%, respectively while that of lipid regulatingagents was is 11.6% and 7.9%, respectively. Patients’ awareness rate of risk factors for their disease was low, and health care providers did not know much about these factors. Conclusions Awareness and use rates of antithrombotic medicine are significantly higher than those of lipid-regulating medicine in ischaemic stroke secondary prevention in Tangshan, but are still at a low level. More efforts should be devoted to knowledge popularization to facilitate secondary prevention.

Cite this article

Download Citations
MENG Linghai,LI Jiong,ZHANG Heqi,SHANG Shuling,and YU Xinyang.. Investigation of medication in secondary prevention in patents with ischemic stroke in Tangshan[J]. Medical Journal of the Chinese People Armed Police Forces. 2012, 23(9): 761-762

References

[1] 中华医学会神经内科分会脑血管病学组、急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中华神经科杂志,2010,43(2):146-153.

[2] 饶明俐,王文志,黄如训.中国脑血管病指南[M].北京:人民卫生出版社,2007:61-63.

[3] 中华医学会神经内科分会脑血管病学组缺血性脑卒中二级预防指南撰写组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010[J].中华神经科杂志,2010,43(2):154-160.

[4] 戴 红,关 骅,王宁华.康复医学[M].北京:北京大学医学出版社,2004:12-13.

[5] 李 踔,倪朝民,韩 瑞.急性脑卒中三级康复的功能结局和经济学评价[J].中华物理医学与康复杂志,2007,29(3):192-195.

[6] Strong K,Mathers C,Bonita R.Preventing stroke:saving lives around the world[J].Lancet Neurology,2007,6:182-185.

[7] 王 力,张 茁. 缺血性卒中二级预防的循证医学证据[J].中华老年心脑血管病杂志,2007,9(8):574-576.

[8] 全国第四届脑血管病学术会议.各类脑血管病诊断要点[J].中华神经科杂志,1996,29(6):379-380.

[9] 居克举,杨 梅,郭建一,等.缺血性卒中二级预防服用拜阿司匹林的依从性随访研究[J].中国全科医学,2010,13(1):153-154.

[10] 中男他汀类药物预防缺血性卒中/短暂性脑缺血发作专家组.他汀类药物预防缺血性卒中/TIA专家建议[J].中华内科杂志,2007,46(1):81-82.

[11] 许明杰,宋世萍,艾 青,等.缺血性脑血管病二级预防他汀类药物应用现状调查[J].脑与神经疾病杂志,2008,16(4): 391-393.

[12] 汪柳霞,董 漪,方 堃,等.缺血性卒中二级预防药物依从性研究[J].中华脑血管病杂志,2010,4(1):11-17.
PDF(413 KB)

Accesses

Citation

Detail

Sections
Recommended

/